Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2010 2
2011 4
2012 1
2013 2
2014 4
2015 5
2016 8
2017 7
2018 7
2019 2
2020 1
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Panda A, Mehnert JM, Hirshfield KM, Riedlinger G, Damare S, Saunders T, Kane M, Sokol L, Stein MN, Poplin E, Rodriguez-Rodriguez L, Silk AW, Aisner J, Chan N, Malhotra J, Frankel M, Kaufman HL, Ali S, Ross JS, White EP, Bhanot G, Ganesan S. Panda A, et al. Among authors: hirshfield km. J Natl Cancer Inst. 2018 Mar 1;110(3):316-320. doi: 10.1093/jnci/djx213. J Natl Cancer Inst. 2018. PMID: 29155997 Free PMC article.
Role of Biomarkers in the Development of PARP Inhibitors.
Ganguly B, Dolfi SC, Rodriguez-Rodriguez L, Ganesan S, Hirshfield KM. Ganguly B, et al. Among authors: hirshfield km. Biomark Cancer. 2016 Mar 9;8(Suppl 1):15-25. doi: 10.4137/BIC.S36679. eCollection 2016. Biomark Cancer. 2016. PMID: 26997874 Free PMC article. Review.
RET rearrangements are actionable alterations in breast cancer.
Paratala BS, Chung JH, Williams CB, Yilmazel B, Petrosky W, Williams K, Schrock AB, Gay LM, Lee E, Dolfi SC, Pham K, Lin S, Yao M, Kulkarni A, DiClemente F, Liu C, Rodriguez-Rodriguez L, Ganesan S, Ross JS, Ali SM, Leyland-Jones B, Hirshfield KM. Paratala BS, et al. Among authors: hirshfield km. Nat Commun. 2018 Nov 16;9(1):4821. doi: 10.1038/s41467-018-07341-4. Nat Commun. 2018. PMID: 30446652 Free PMC article.
46 results